NZX-listed medical cannabis firm Cannasouth’s planned purchase of its cultivation joint venture has fallen over after it raised only $4.7 million of the $6m needed to satisfy a condition.
In early July, the medical cannabis company announced a capital raise of $6m with the ability to accept
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
